Intravenous Iron May Increase Depression Among Hemodialysis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

112 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-14

Study Completion Date

2017-05-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the aim of this study is to assess whether increased ferritin after intravenous iron therapy will lead to increased prevalence of major depression among treated patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact and Mechanism of Depression on Cardio-cerebral Vascular Events and Arteriovenous Fistula Dysfunction in MHD Patients

NCT06070805

Cardio-cerebral Vascular Events Arteriovenous Fistula Dysfunction

COMPLETED

Identifying and Treating Depression in Hemodialysis Patients

NCT03390933

Depression Hemodialysis-Induced Symptom

COMPLETED PHASE4

Morbidity and Mortality Among Dialysis Patients After Treatment for Depression

NCT00442429

Depression ESRD

UNKNOWN

Feasibility RCT of ACT Self-help for Depression in Haemodialysis

NCT02565056

End-stage Renal Disease Depression

COMPLETED NA

Cognitive Behavioral Treatment of Depression in ESRD Patients on Dialysis

NCT00618475

End Stage Renal Disease Depression

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Hemodialysis Complication Iron Deficiency Anemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intravenous iron therapy

each patient with iron def anemia received an IV syringe of iron sucrose 100 mg every dialysis session for 10 doses

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. age was above 19 years,
2. patient on maintenance hemodialysis,
3. patient had iron deficiency anemia (ferritin \> 100 ng/ml)

Exclusion Criteria

1. patient has history of depression or already using antidepressant medication,
2. Lack of ferritin level increase ≥ 50% from baseline level before IV iron administration,
3. patient already on oral or intravenous iron supplement

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No